Administration study as a part of research toward the influence of growth hormone releasing peptide GHRP-2 on detection of rhGH
Not Applicable
- Conditions
- ot applicable
- Registration Number
- JPRN-jRCT1080220995
- Lead Sponsor
- Mitsubishi chemical Medience Corporation
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Sex
- Male
- Target Recruitment
- 15
Inclusion Criteria
Weight: more than 50 kg and under 66kg
BMI: more than 18.5 and under 25
Exclusion Criteria
Hypersensitive to drugs,
A hystory of alcoholism of drug addiction,
Ethical or OTC pharmaceuticals administration within two before scheduled administration of the study,
Supplement, grapefruit or its products, or foods containing Hyperrium perforatum consumed within one week before scheduled administration of the study.
Not less than 200 ml of blood is collected within 30 days or not less than 400 ml of blood is collected within 90 days before scheduled administration of the study.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method